New Infants Respiratory Distress Syndrome Treated with Shenfu Decoction and Compound Red Sage Injection in Assistance
- VernacularTitle:参附汤加复方丹参注射液辅助治疗新生儿呼吸窘迫综合征
- Author:
Guiran YANG
;
Shuzhen LI
;
Ruixia YAN
- Publication Type:Journal Article
- Keywords:
respiratory distress syndrome;
Shenfu Decoction;
Compound Red Sage Injection;
alveolus superficial active substance;
new infants
- From:
Journal of Zhejiang Chinese Medical University
2006;0(05):-
- CountryChina
- Language:Chinese
-
Abstract:
[Objective] To observe the clinical effect of Shenfu Decoction and Compound Red Sage Injection on new infants respiratory distress syndrome.[Method] Randomly divide 42 cases into 2 groups,control group(1)take the integrated therapy:CPAP,oxgen,warming,keeping wet and anti-bacterial;the treatment group(1)take the Shenfu Decoction and Compound Red Sage Injection.Compare their cure rates after 7d.[Result] In group 1,survivable rate was 95.23%,cure rate 71.4%;and 80.95% and 47.62% respectively for other group;the clinical symptoms,signs,blood-gas analysis and X-ray result were all better in group 1 than group 2.[Conclusion] Oral taking Shenfu Decoction and Compound Red Sage Injection for vein drip can help relieve infants clinical symptoms and pass alveolus superficial active substance lack period.
